SpeedWeed

MARCH 31, 2021

The CDC report found “a precipitous national decline in adolescent treatment admissions, particularly in states legalizing recreational marijuana use,” states study author Jeremy Mennis, Ph.D. “7 CDC data aligns with most surveys. CDC data aligns with most surveys. The data on this issue is clear, consistent, and available.

Treatment 52

Treatment Data Vaping Recreational 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

SpeedWeed

FEBRUARY 21, 2021

If successful, data from (Kaminski’s) pre-clinical study would be used as part of the support for an Independent New Drug filing with the FDA,” said Small-Howard. View original article.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

Veriheal

MAY 18, 2023

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

JUNE 19, 2022

Other strategies include filing patents on synthetic pathways, extraction protocols, novel formulations, methods of use, and methods of treatment in various disease conditions. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. The authors note, however, that the data doesn’t include patient outcomes.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” That seemed to make all the difference. © Copyright, Project CBD.

THC 144

THC CBD Sleep Clinical Trials 144

Cannabis Law Report

AUGUST 27, 2022

The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. On these grounds and others, the petitioners challenged various Sections of the NDPS Act as being violative of Articles 14, 19, 21, 25 and 29 of the Constitution. Appeals to Parliament.

Consumption 98

Consumption Cultivation Research and Development Cannabis 98

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Project CBD

JANUARY 24, 2019

In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Around 10-20% of patients stopped taking various medications (mostly antipsychotic and antiepileptic drugs) within 6 months of starting cannabis treatment.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications.

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

SEPTEMBER 7, 2021

Despite these considerations, HHC vape carts hit the market without an accredited Certificate of Analysis (COA) or toxicity data. Old data suggests that beta-HHC is 1000% more potent than D9-THC. Hydrogenated cannabinoids have been studied on mice and this research suggests that HHC is a promising cancer treatment. Sources.

THC 93

THC Cannabinoids Digestion Data 93

Cannabis Law Report

MAY 26, 2022

But some experts are calling for offering more treatment to those addicted to marijuana to prevent repeat offenses, instead of imposing criminal penalties, citing data that shows many users of marijuana in Japan are young people. Offenders would face severe punishment if the new provision is introduced.

Legalization 52

Legalization Marijuana Epilepsy THC 52

Veriheal

SEPTEMBER 30, 2021

Cannabis is an ideal substance to use during the various stages of cancer treatment but most especially after chemotherapy. The team of researchers analyzed data from nearly 20,000 people over a four-year period and found that cannabis use among cancer patients peaked at 9%.

Patients 98

Patients Research and Development Treatment Consumption 98

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE:

Research and Development 105

Research and Development Data Conditions Therapy 105

Veriheal

JANUARY 26, 2023

In this article, we’ll explore how the potential advantages of cannabis might help stabilize symptoms associated with bipolar disorder. Researchers employed Releaf App data to uncover this remarkable correlation, suggesting that marijuana might play a role in treating certain mental health conditions.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. Read their full article at. The Guardian writes.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

SEPTEMBER 2, 2022

The peer-reviewed research article, published in the journal PLOS ONE on Wednesday, looked at stock return and prescription drug sales data for 556 pharmaceutical companies from 1996 to 2019, analyzing market trends before and after the enactment of medical and adult-use cannabis legalization laws at the state level. Read full article.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Cannabis Law Report

JUNE 24, 2022

This statistic is telling of a racial hiring bias when compared to census data that shows 55% of Denver residents are white, while 40% are Black or Hispanic. Another approach is to provide minorities with preferential treatment in licensing.

Legislation 52

Legislation Cannabis Conditions Programs 52

Cannabis Law Report

JUNE 2, 2021

The latest article in Healthcare Business Today cites the company’s Multiomics Advanced Technology™ (MAT) as the driver for more accurate predictions about disease states and individual responses to diseases and treatments that will make medicine truly personalized.

Medicine 90

Medicine Business Treatment Data 90

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC7400098/.

CBD 144

CBD Seed-To-Sale Food Access 144

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. This article by Hannah Laclaire was originally published by the Portland Press Herald on March 19, 2021.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. This article by Hannah Laclaire was originally published by the Portland Press Herald on March 19, 2021.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

Healer

MARCH 26, 2021

This article from the Portland Press Herald includes information from a study by Dr. Sulak in 2016 that showed 85% of 525 of his practice’s patients reported a decrease in or cessation of opioid use when using medical cannabis. This article by Hannah Laclaire was originally published by the Portland Press Herald on March 19, 2021.

Chronic Pain 52

Chronic Pain Therapy Data Patients 52

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. Cannabis Therapy and Maryland Residents Cannabis therapy has become a viable treatment option for many Maryland residents.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

SpeedWeed

APRIL 10, 2021

Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms,” was posted online last month prior to publication by the journal Experimental and Clinical Psychopharmacology. The data revealed a sustained improvement in the participants’ symptoms.

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

Veriheal

MARCH 29, 2023

In this article, we use science to provide clarity and direction on the truth behind marijuana legalization in an evidence-based landscape. 31, 2017, researchers relied heavily on data related to member enrollment information, diagnostic codes, and pharmacy claims integrated with a secure patient identifier. 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

CannaMD

JANUARY 6, 2021

Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.

Recreational 105

Recreational Marijuana Data Collective 105

The Cannigma

FEBRUARY 14, 2023

Cannabis – including THC and CBD – has a growing role in the treatment of these conditions. And many women are using it for this , despite this lack of good data. Please see the linked articles for more specifics. If your problem is falling asleep, then using inhalation may make sense.

Strains 59

Strains Tincture Terpenes Sleep 59

Cannabis Law Report

DECEMBER 20, 2021

The punishment will be replaced by admitting the convict in rehabilitation units for addicts, with the aim of giving the “patient” the opportunity to correct behaviour and receive treatment and rehabilitation instead of just imprisonment. This data is prohibited in other than cases stipulated by the law from disclosing or broadcasting.

Law 52

Law Data Treatment Patients 52

Cannabis Law Report

DECEMBER 27, 2019

The main goals with conducting clinical studies, which could include observational studies or clinical trials, are to explore the causes of a disease or its symptoms, test a treatment, and learn how a certain behaviour affects patients’ health. The trials focus on correlations between treatments and outcomes in real-world settings.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

SpeedWeed

FEBRUARY 18, 2021

It used a double-blind, randomized, placebo-controlled method to ensure the data would be accurate and unbiased, and the patients would not know what they were getting. We also observed a significant improvement in quality of life, general health, appetite, libido , concentration, and patient satisfaction with the treatment.”.

Clinical Trials 52

Clinical Trials Treatment Data THC 52

CannaMD

MARCH 3, 2021

A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. It’s important to note that the Washington data was more limited than the Colorado data.

Legalization 119

Legalization Marijuana Data Safety 119